Transplantology in Israel typically costs from $192,000 to $343,300. Final expenses depend on the type of organ or tissue, donor compatibility, and the patient's age. Israel offers high success rates with savings of approximately 35-60% compared to the United States, making it a key destination for specialized cell therapies and living donor procedures.
Typical Transplantology Costs in Israel
Most transplant procedures are performed in Tel Aviv and Jerusalem, where world-class medical centers are concentrated. While costs are generally consistent across the country's major hubs, you should consult with a specialist to get accurate pricing and legal guidance for your specific case.
| Israel | España | Turquía | |
| Trasplante de riñón | de $95,000 | de $80,000 | de $18,000 |
| Trasplante de pulmón | de $190,000 | de $300,000 | de $180,000 |
| Trasplante de hígado | de $165,000 | de $120,000 | de $45,000 |
| Trasplante de córnea | de $14,200 | de $12,546 | de $3,500 |
| Trasplante de corazón y pulmones | de $295,000 | de $600,000 | de $250,000 |
Bookimed no añade cargos extra a los precios de los tratamientos de Trasplantología. Las tarifas proceden de las listas de precios oficiales de las clínicas. Pagará directamente en la clínica por su tratamiento a su llegada al país.
Bookimed está comprometido con su seguridad. Solo trabajamos con las clínicas que mantienen altos estándares internacionales en el tratamiento de Trasplantología y tienen las licencias necesarias para atender a pacientes internacionales en todo el mundo.
Bookimed ofrece asistencia experta gratuita. Un coordinador médico personal le apoya antes, durante y después del tratamiento, resolviendo cualquier problema. Nunca estará solo en su viaje médico de procedimientos de Trasplantología.
El Prof. Amos Toren, MD, PhD, MHA, es hemato-oncólogo pediátrico y especialista en trasplante de médula ósea (TMO). Fue director de Hemato-oncología Pediátrica y TMO en el Centro Médico Sheba.
Está certificado en pediatría, hemato-oncología pediátrica y trasplante de médula ósea. Tiene un doctorado en genética humana. Fue director de la División de Hematología de la Universidad de Tel Aviv durante dos mandatos. Es miembro de ASH, COG, ESPHI, EBMT y CIBMTR. También forma parte del Comité de Sangre de Cordón del Ministerio de Salud.
Dirigió uno de los programas de oncología pediátrica y TMO más avanzados de Israel. El programa atendía a niños y adultos jóvenes. Su enfoque incluye leucemia y linfoma, inmunodeficiencias y cánceres raros. Se especializa en TMO y terapia con células CAR T.
Su investigación traslacional abarca células CAR T, células asesinas inducidas por citocinas, tumores cerebrales pediátricos y terapias dirigidas. Ha colaborado con St. Anna, los NIH y St. Jude. Sus publicaciones incluyen estudios sobre la profilaxis del trasplante pediátrico de células madre y la resistencia a los inhibidores de PARP.
Dra. Hana Golan, MD, dirige la División de Hemato-Oncología Pediátrica y Trasplante de Médula Ósea (TMO) del Centro Médico Sheba. Se especializa en cánceres infantiles, con énfasis en el neuroblastoma y otros tumores sólidos de alto riesgo.
Encabeza uno de los programas de oncología pediátrica más avanzados de la región. Atiende casos complejos y de alto riesgo y ejerce en un hospital clasificado entre los 10 mejores del mundo.
Es la investigadora principal del protocolo ESIOP para neuroblastoma de alto riesgo. Participa como investigadora en ensayos internacionales de fase I/II y se desempeña como coordinadora nacional de protocolos oncológicos multicéntricos. Lideró el desarrollo de protocolos informatizados de quimioterapia y bases de datos de pacientes para mejorar la seguridad.
Obtuvo su título de médica en el Technion. Completó residencias en Pediatría y en Hemato-Oncología Pediátrica en Sheba. Realizó investigación avanzada en inmunología del trasplante en el Instituto Weizmann. Está certificada en Pediatría y en Hematología-Oncología Pediátrica. Es profesora sénior en la Facultad de Medicina Sackler de la Universidad de Tel Aviv. Su investigación se centra en las células madre del cáncer, las terapias dirigidas, las neoplasias resistentes al tratamiento y la oncología relacionada con cannabinoides.
El Prof. Ido Nachmany encabeza el Segundo Departamento de Cirugía del Centro Médico Sheba. Se especializa en cirugía HPB (hepato-pancreatobiliar) y robótica para enfermedades del hígado, páncreas y vías biliares, y para tumores neuroendocrinos gastrointestinales. También realiza cirugía suprarrenal, del bazo y del estómago. Forbes lo incluyó entre los mejores médicos de Israel.
Impulsa técnicas robóticas y laparoscópicas mínimamente invasivas. El objetivo es mayor precisión y una recuperación más rápida.
Credenciales: Profesor titular en la Universidad de Tel Aviv. Miembro de la ASTS y de la IHPBA. Completó subespecializaciones en HPB y trasplante abdominal en el Instituto de Trasplantes Thomas E. Starzl. Acreditado en Cirugía General (Israel), Trasplante de Órganos Abdominales (ASTS) y Cirugía HPB (Universidad de Pittsburgh). Ha publicado en Cancer Research, Journal of the American College of Surgeons y European Journal of Surgical Oncology.
La Dra. Einat Shacham‑Shmueli es oncóloga médica sénior en la Clínica Gastrointestinal del Centro Oncológico del Centro Médico Sheba. Trata cánceres de colon, estómago y páncreas. También maneja la enfermedad metastásica. Emplea diagnósticos de precisión y biomarcadores, terapias sistémicas y radioterapia. La atención se brinda dentro de un equipo multidisciplinario.
Ha publicado más de 25 artículos revisados por pares sobre oncología gastrointestinal, biología tumoral y nuevos tratamientos. Su trabajo incluye estudios sobre el uso de stents para la obstrucción colónica maligna. Se desempeña como investigadora en programas internacionales, incluidos el NCI, el Radiation Therapy Oncology Group y el Cancer Therapy Evaluation Program.
Educación: MD, Universidad de Tel Aviv. Residencia en Oncología, Centro Médico Tel Aviv Sourasky. Formación avanzada en oncología gastrointestinal, UCSF. Acreditaciones: Certificada por junta en Oncología y Gastroenterología. Miembro de la Sociedad Israelí de Oncología y Radioterapia.
Escrito por Вероника Казина
Escrito por Ana Hurevska
Escrito por Veronika Kazina
International patients cannot practically receive organs from deceased donors in Israel due to severe legal restrictions. The 2008 Organ Transplant Law prioritizes citizens and residents. Foreigners are placed at the bottom of the national waiting list. This makes access to deceased donor organs nearly impossible for non-residents.
Bookimed Expert Insight: While deceased donation is restricted, Israel excels in complex living donor procedures. Data shows high success rates at facilities like Sourasky Medical Center, which treats 1,800,000 patients annually. For international cases, focusing on living kidney or liver donation with a compatible family member is the only viable path.
Patient Consensus: Patients note that hospital staff confirm ineligibility for deceased donor organs upfront. Many suggest exploring living donation or looking at other countries if a family donor is unavailable.
Israel reports some of the world's highest transplant success rates. Kidney transplant recipients see 90% to 95% 1-year survival. Leading centers like Sheba Medical Center and Hadassah Medical Center achieve these results through advanced HLA-typing and living-donor programs. Most procedures perform above global averages.
Bookimed Expert Insight: Israel's unique point system for organ donors significantly reduces waiting lists. Data shows centers like Sheba and Sourasky handle massive volumes, with over 1,800,000 patients annually. This high frequency allows surgeons to refine techniques, leading to record-breaking months with over 50 successful transplants nationwide.
Patient Consensus: Patients emphasize choosing living-donor procedures whenever possible for superior outcomes. They also recommend verifying surgeon credentials through official health ministry records before the procedure.
Leading transplant centers in Israel include Hadassah Medical Center, Sourasky Medical Center, and Sheba Medical Center. These JCI-accredited institutions are recognized by Newsweek as the world's best hospitals. They specialize in complex kidney, liver, heart, and bone marrow transplantations for international patients.
Bookimed Expert Insight: Israeli medical centers often consolidate expertise by appointing Forbes-ranked specialists to lead dedicated departments. For instance, Hadassah Medical Center features multiple doctors like Dr. Gal Goldstein and Dr. Polina Stepensky who are recognized as top specialists. This creates a high-density environment of peer-reviewed expertise within a single facility.
Patient Consensus: Patients note that organ matching can often happen faster in Israel than in Europe due to local donation laws. They emphasize the importance of securing second opinions and navigating the bilingual care system with the help of patient advocates.
Donor operations in Israel primarily utilize minimally invasive techniques like laparoscopic and robotic-assisted surgery. These methods reduce recovery time for living donors of kidneys and livers. Surgeons use high-precision tools like the Da Vinci system to ensure safety and organ viability during the procedure.
Bookimed Expert Insight: Israeli centers like Sourasky Medical Center (Ichilov) prioritize hybrid laparoscopic techniques. This approach balances surgical speed with minimal scarring. Our data shows liver donors return to activities twice as fast compared to traditional open surgery. Choosing clinics with Da Vinci technology often results in shorter hospital stays.
Patient Consensus: Donors often mention that small incisions and specialized pain management make the recovery much easier. Many feel reassured by the thorough pre-op testing like HLA-typing and DNA-tests.
English communication is standard across Israeli transplant facilities. Major centers like Sheba and Hadassah maintain dedicated international departments. Most transplant surgeons, including Prof. Michael Shapira at Sourasky Medical Center, are fluent. They often complete fellowships in the US or Europe.
Bookimed Expert Insight: Our data shows that top-rated clinics like Sheba and Sourasky handle massive patient volumes. Sheba treats 1.5 million patients yearly across 1,990 specialties. This high volume drives these centers to standardize English communication. It ensures safety for the thousands of international patients they serve.
Patient Consensus: Patients note that while surgeons are usually fluent, you should explicitly request English versions of discharge papers. Coordinating with the international office in advance helps avoid potential language friction with administrative staff.
Israel's Don't Give, Don't Get rule is a priority system for organ transplants established by the 2008 Organ Transplant Act. It grants preferential standing on waiting lists to registered donors. The policy applies when two patients have equal medical urgency for a transplant procedure.
Bookimed Expert Insight: Israeli medical centers like Sheba and Sourasky manage massive patient volumes, often exceeding 1,500,000 annually. This high activity level makes the priority rule a critical tie-breaker. Because these centers perform tens of thousands of operations yearly, being in a higher priority tier can significantly impact wait times for stable patients.
Patient Consensus: Patients note that international travelers usually default to the lowest priority tier unless they can provide official donor registration documents. It is important to discuss your donor status with your treating physician early to understand how it affects your timeline.
Israeli hospitals accommodate religious needs through standardized services including kosher catering, prayer rooms, and Shabbat-compliant facilities. Joint Commission International (JCI) accredited centers like Sheba and Hadassah integrate spiritual values into transplant care. Facilities provide access to clergy and specialized dietary plans to support diverse patient backgrounds.
Bookimed Expert Insight: Israeli transplant centers like Hadassah and Sheba Medical Center manage over 1,000,000 patients annually. This high volume makes religious accommodation a routine part of clinical flow. For example, medical teams are specifically trained in halacha, the Jewish law, to balance life-saving transplant procedures with religious observance.
Patient Consensus: Patients note that while Jewish customs are the default, staff readily provide halal food and prayer space for other faiths. Many recommend bringing personal items like a Bible or prayer rug to feel more at home.